The disclosure relates generally to cardiac treatment devices and techniques, and in particular, to methods and devices for mitral valve repair.
The heart includes four heart valves, which allow blood to pass through the four chambers of the heart in one direction. The four valves are the tricuspid, mitral, pulmonary and aortic valves. The four chambers are the right and left atria (upper chambers) and right and left ventricle (lower chambers).
The mitral valve is formed by two leaflets, which are known as the anterior leaflet and the posterior leaflet, which open and close in response to pressure placed on the leaflets by the pumping of the heart. There are several problems that can develop or occur with respect to the mitral valve. Such problems include mitral valve regurgitation (MR), in which the mitral valve leaflets do not close properly, which can cause leakage of the mitral valve. Severe mitral regurgitation can adversely affect cardiac function and compromise a patient's quality of life and life-span. There are several techniques directed to correcting mitral valve regurgitation, which include valve replacement, chordae tendinea shortening or replacement and mitral annular repair also known as annuloplasty.
Current techniques to correct mitral regurgitation include repairing the mitral valve via open heart surgery while a patient's heart is stopped and the patient is on cardiopulmonary bypass. Such techniques are highly invasive that have inherent risks. It would be desirable to provide a less invasive procedure for repairing a mitral valve.
One embodiment disclosed herein includes a method of repairing a mitral valve of a patient's heart that comprises accessing a right ventricle of the patient's heart with a catheter extending through a venous or right side of the heart to access the left ventricle and and with the catheter securing a mitral valve leaflet.
Another embodiment disclosed herein is a chordae replacement system that can include a catheter and a chordae replacement implant. The catheter can have an elongate, flexible tubular body with a proximal end and a distal end. The catheter can be configured for transvascular access into the right ventricle, through the intraventricular septum and into the left ventricle. The chordae replacement implant can be deployably carried by the catheter. The chordae replacement implant can comprise an elongate body having a proximal end with a proximal tissue anchor and a distal end with a mitral valve leaflet attachment anchor.
Another embodiment disclosed herein is method of repairing a mitral valve, the method comprising with a catheter transvascularly accessing the right ventricle and extending the catheter through the intraventricular septum and into the left ventricle and deploying a chordae replacement implant with the catheter.
Normal mitral leaflet 10 connections in the left ventricle include chordal attachments 12 from the free margin of the mitral leaflet 10 to the papillary muscles 14, which are shown in
The repair and reconnection of a flail leaflet (a ruptured chord 7 being shown in
A different technique would be to access the right ventricle 16 via trans-femoral vein 18 threading a catheter 20 or catheters to the apex or bottom of the right ventricle 16 as shown in
The grounding plug or anchor 40 could be similar to an Amplatz device used for closing an ASD or another device to distribute forces to a larger area distributing the load throughout a larger surface area in the right ventricle or within the interventricular septal wall as shown in
Access into the femoral vein could occur with a guidewire 70 measuring about 0.035 inches in diameter and about 180 centimeters in length. An introducer sheath could follow to provide a conduit to pass additional catheters in and out of the femoral access site as shown in
An access pathway to the left atrium through a trans-septaL puncture can be completed by also via the femoral artery at the groin to advance a guidewire and catheter system in a similar manor as described above. This would allow for an above and below intimate contact of the mitral valve leaflets to secure and suture them back into proper positioning. The above-catheter from the left atrium and below—catheter from the left ventricle, via right ventricle, can locate and hold the position of the flail leaflet for suture piercing and tethering back into its proper position to coapt with the adjacent leaflet eliminating the mitral regurgitated blood flow. Piercing needles and strain relieving pledgets 75 could be used to pass suture 75 and distribute the local forces at the leaflet attachment site as shown in
Catheters would be constructed of common polymers including nylon, Teflon, urethanes, and other commonly used materials having a proximal and distal end with a guidewire port through s The catheter curves needed would be pre-set, fixed or actively curved through differential forces transmitted via pull wires or tubes to bias one direction or another providing a column compression on one side of the catheter relative to the other. Column and tubular strength could be provided by imbedded coiled wires, braided with ribbon or round wire, laser cut tubes or skeletal structures to form a defined structure and or curve needed to gain access. Variable durometers, construction techniques are well known in the industry to allow for specific pushability, stiffness and curves needed to deliver. Coatings and surface treatments both internally and externally could aid in relative movement between vessel walls and between wires and other catheters. The tensioning means could be provided by a pull-wire extending from the distal end of the catheter to the handle of the proximal section. This pull wire could be activated by rotational screws translated into longitudinal forces pulling a connection to the distal end of the catheter. The overall length of the femoral catheter access would be about 100 cm in length and have a through lumen to accept a guidewire for positioning within the bodies vasculature. The overall length of the internal jugular catheter would be about 60 cm in length. Both catheters would be about 6-20 French in diameter with at least one lumen from the proximal distal end of the delivery system.
Access from the femoral vein will allow for catheterization through the tricuspid valve and into the right ventricle. At the apex of the right ventricle an access will be attained by advancing a needle or catheter in through the septal wall gaining access to the left ventricle. Use of a needle, ultrasonic or coring tool to pass a guidewire from right ventricle to left ventricle is the pathway and access route to repair the mitral valve. Once a needle and or guidewire can be advanced additional tools such as catheters can be utilized to repair the mitral valve. The septal wall can be over 1 centimeter in thickness so maintaining an access port may be achieved by a balloon dilatation, guide catheter or access conduit to pass tools and catheters through during the repair. A steerable sheath, catheter or conduit may allow an easier access direction to the specific area of the mitral valve for repair. Adjustments made rotationally and or angularly can be fixed or locked into position once optimal positioning is obtained. This can be achieved by a pre-shaped curve configuration whereas the catheter is curved down through the tricuspid valve and across the ventricular septal wall then pointing upward toward the mitral valve. This shape can be fixed or variable based upon patient needs and anatomy. Guidewires measuring about 0.035 inches in diameter and about 180 to 300 centimeters in length will allow for catheters to be advanced over and allow exchange of additional tools to be interchanged. Expandable dilators can be used expand areas where tight access is required or larger bore catheters are required. Catheter sizing may start from about 6 French to about 24 French in diameter and range from lengths including 90 centimeters to 160 centimeters. Construction of these catheters can be of normal polymers including nylon, polyurethane, polyethylene or other similar polymers. Braids, coils or laser cut tubes can be used within the catheter construction to better support inner diameters, shapes or curves required. These materials can also include stainless steel, Nitinol, Platinum or MP35N metallic suitable for catheter construction.
Nesting multiple catheters inside one another will provide for additional curves, movement, and translational freedoms. In one embodiment a larger catheter (24 French inner diameter) to access the apex of the right ventricle could be used to position a stable base from which to advance an inner catheter (18 French inner diameter) through the ventricular septaI wall and a third catheter could be advanced through this catheter measuring about 14 French inner diameter to advance into the left ventricle directing toward the mitral valve. These catheters would allow for multiple adjustments and angles for various anatomies. The ability to translate, rotate and lock position of each of these catheters together or independently will provide a stable platform to deliver repair tools to the valve. Locking means for each of these catheters nested inside one another can be achieved by an expansion via diameter change using a hydraulic pressure, a mechanical expansion via rotational means creating an eccentric lock or a longitudinal pull to create a differential diameter between the catheters. This push-pull translation could force the catheter to accordion creating a larger bump within one catheter.
Additionally, push pull wires could force the catheters into predetermined shapes and curves in single or multiple plains. By laser cutting a specific pattern into the catheter inner frame a shape can be forced by a pull wire reducing one side of the catheter length while collapsing the round column shape of the catheter creating a shape as determined by the laser cut element internal to the catheter. As an example, a slot could be cut into one side of the tube and a tension wire attached at the distal end of the tube. As tension is applied to the wire, a collapsing of the slotted side of the tube would result in curve or bias to the tubular element. These slots could also be complex shapes to lock the rotational angle into a pre-determined shape. This complex shape could be a chevron, angled cut, radiused shape or another detailed pattern to stop the collapsing of the tube at a predetermined radius. This pattern could also be rotated about the tube to create three-dimensional shapes and curves out of a single plane.
This patterning would be laser cut into the inner tube of the catheter and be constructed from a metallic or polymer and embedded into the wall of the catheter wall.
The first angular curve would be about 180 degrees changing the direction of the catheter from the femoral access through the tricuspid valve and directing toward the apex of the right ventricle. The second curve in this catheter would be about a 90 degree turn toward the ventricular septal wall making a “Shepard's Crook” shape. This 90 degree direction could be also attained with a second inner catheter passed through the first larger diameter catheter to direct the access through the ventricular septal wall. This would require a 90 degree curve to redirect the tip toward the septal wall. Once a penetration of the septaI wall is achieved another 90 degree curve would be required to direct the catheter toward the mitral valve. Between these two 90 degree curves and separation of about 1 to 2 centimeters is required to traverse the septal wall tissue. This straight section could be preshaped into the curve configuration and be actuated with a single pull wire or multiple pull wires. The preferred embodiment would utilize the first catheter to attain the 90 degree curve toward the ventricular septal wall.
The next inner catheter directed toward the mitral valve could be advanced toward the valve leaflets in the left ventricle. Directed and placed below the leaflet the catheter tip could locate the free margin of the mitral valve leaflet to secure a tether for a ruptured chord or flail leaflet repair. Single or multiple chords can emanate from a single access point or from separate locations along the valve leaflet. From above through a trans-septaI access a second catheter could located the top side of the leaflet along the same free margin of the leaflet. Locating these two catheters coaxially could be achieved through a magnetic tip that is built into the catheter or advanced through each central lumen of the catheters.
Locating these two catheters above and below the leaflet pinching one another with the leaflet sandwiched in between would allow for an access through the leaflet for chordal repair or tethering to secure through the lower access point originating from the right ventricle. The chordal repair could be a PTFE suture or another material suitable for permanent implantation. With the lower access point extending into the right ventricle an anchor could be located completely in the right ventricle or within the ventricular septal wall exposing only the replacement suture material in the left ventricle. Anchor designs can be similar to a barbed anchor with a single or plurality of barbs to engage the tissue, a plug to hold from the right ventricle side of the septal wall or a screw means to engage the tissue in the right or left ventricle. The attachment of the tissue anchor to the chordal leaflet attachment can be adjusted while monitoring the tension of the chord or the echo results live during or after the implantation of the chords and anchor system.
This application is a continuation of U.S. application Ser. No. 16/024,439, filed Jun. 29, 2018, which is a continuation of PCT Patent Application No. PCT/US2016/069567, filed Dec. 30, 2016, which claims a priority benefit to U.S. Provisional Application No. 62/383,338, filed Sep. 2, 2016 and U.S. Provisional Application No. 62/273,300, filed Dec. 30, 2015, the entire disclosure of each these non-provisional and these provisional applications are hereby incorporated by reference herein for all purposes in their entireties and should be considered a part of this specification.
Number | Name | Date | Kind |
---|---|---|---|
4677065 | Buchbjerg et al. | Jun 1987 | A |
4969870 | Kramer et al. | Nov 1990 | A |
5329923 | Lundquist | Jul 1994 | A |
5456708 | Doan et al. | Oct 1995 | A |
5674217 | Wahlstrom et al. | Oct 1997 | A |
6269819 | Oz | Aug 2001 | B1 |
6458107 | Ockuly | Oct 2002 | B1 |
6461366 | Seguin | Oct 2002 | B1 |
6569105 | Kortenbach et al. | May 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6743239 | Kuehn et al. | Jun 2004 | B1 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6770083 | Seguin | Aug 2004 | B2 |
6840246 | Downing | Jan 2005 | B2 |
6978176 | Lattouf | Dec 2005 | B2 |
7048754 | Martin et al. | May 2006 | B2 |
7083628 | Bachman | Aug 2006 | B2 |
7191545 | Yi | Mar 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7288097 | Seguin | Oct 2007 | B2 |
7464712 | Oz et al. | Dec 2008 | B2 |
7563267 | Goldfarb et al. | Jul 2009 | B2 |
7604646 | Goldfarb et al. | Oct 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7632308 | Loulmet | Dec 2009 | B2 |
7635386 | Gammie | Dec 2009 | B1 |
7637903 | Lentz et al. | Dec 2009 | B2 |
7655015 | Goldfarb et al. | Feb 2010 | B2 |
7666204 | Thornton et al. | Feb 2010 | B2 |
7682369 | Seguin | Mar 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7871368 | Zollinger et al. | Jan 2011 | B2 |
7871433 | Lattouf | Jan 2011 | B2 |
7887552 | Bachman | Feb 2011 | B2 |
7914515 | Heideman et al. | Mar 2011 | B2 |
7914545 | Ek | Mar 2011 | B2 |
8075570 | Bolduc et al. | Dec 2011 | B2 |
8100923 | Paraschac et al. | Jan 2012 | B2 |
8172872 | Osypka | May 2012 | B2 |
8241304 | Bachman | Aug 2012 | B2 |
8252050 | Maisano et al. | Aug 2012 | B2 |
8273054 | St. Germain et al. | Sep 2012 | B2 |
8303622 | Alkhatib | Nov 2012 | B2 |
8382829 | Call et al. | Feb 2013 | B1 |
8394113 | Wei et al. | Mar 2013 | B2 |
8409273 | Thornton et al. | Apr 2013 | B2 |
8465500 | Speziali | Jun 2013 | B2 |
8475472 | Bachman | Jul 2013 | B2 |
8475525 | Maisano et al. | Jul 2013 | B2 |
8480730 | Maurer et al. | Jul 2013 | B2 |
8535339 | Levin et al. | Sep 2013 | B2 |
8545551 | Loulmet | Oct 2013 | B2 |
8545553 | Zipory et al. | Oct 2013 | B2 |
8603066 | Heidman et al. | Dec 2013 | B2 |
8690939 | Miller et al. | Apr 2014 | B2 |
8718794 | Helland | May 2014 | B2 |
8740940 | Maahs et al. | Jun 2014 | B2 |
8778016 | Janovsky et al. | Jul 2014 | B2 |
8814824 | Kauphusman et al. | Aug 2014 | B2 |
8852213 | Gammie et al. | Oct 2014 | B2 |
8940042 | Miller et al. | Jan 2015 | B2 |
8945211 | Sugimoto | Feb 2015 | B2 |
8951285 | Sugimoto et al. | Feb 2015 | B2 |
8951286 | Sugimoto et al. | Feb 2015 | B2 |
8961594 | Maisano et al. | Feb 2015 | B2 |
8961596 | Maisano et al. | Feb 2015 | B2 |
9011520 | Miller et al. | Apr 2015 | B2 |
9023065 | Bolduc et al. | May 2015 | B2 |
9050187 | Sugimoto et al. | Jun 2015 | B2 |
9131939 | Call et al. | Sep 2015 | B1 |
9180007 | Reich et al. | Nov 2015 | B2 |
9198649 | Karapetian et al. | Dec 2015 | B2 |
9241702 | Maisano et al. | Jan 2016 | B2 |
9259218 | Robinson | Feb 2016 | B2 |
9277994 | Miller et al. | Mar 2016 | B2 |
9307980 | Gilmore et al. | Apr 2016 | B2 |
9314242 | Bachman | Apr 2016 | B2 |
9474606 | Zipory et al. | Oct 2016 | B2 |
9492264 | Fifer et al. | Nov 2016 | B2 |
9572667 | Solem | Feb 2017 | B2 |
9579097 | Shluzas | Feb 2017 | B2 |
9636205 | Lee et al. | May 2017 | B2 |
9636224 | Zipory et al. | May 2017 | B2 |
9668860 | Kudlik et al. | Jun 2017 | B2 |
9681864 | Gammie et al. | Jun 2017 | B1 |
9681964 | MacKenzie | Jun 2017 | B2 |
9693865 | Gilmore et al. | Jul 2017 | B2 |
9724195 | Goodwin et al. | Aug 2017 | B2 |
9750493 | Robinson et al. | Sep 2017 | B2 |
9788948 | Gilmore et al. | Oct 2017 | B2 |
9801720 | Gilmore et al. | Oct 2017 | B2 |
9814454 | Sugimoto et al. | Nov 2017 | B2 |
9877833 | Bishop et al. | Jan 2018 | B1 |
9907547 | Gilmore et al. | Mar 2018 | B2 |
9907681 | Tobis et al. | Mar 2018 | B2 |
10022114 | Gilmore et al. | Jul 2018 | B2 |
10039643 | Gilmore et al. | Aug 2018 | B2 |
10039644 | Navia et al. | Aug 2018 | B2 |
10052095 | Gilmore et al. | Aug 2018 | B2 |
10058323 | Maisano | Aug 2018 | B2 |
10076327 | Ellis et al. | Sep 2018 | B2 |
10076658 | Hastings et al. | Sep 2018 | B2 |
10130791 | Heideman et al. | Nov 2018 | B2 |
10159571 | de Canniere | Dec 2018 | B2 |
10206673 | Maisano et al. | Feb 2019 | B2 |
10231727 | Sutherland et al. | Mar 2019 | B2 |
10238491 | Tobis | Mar 2019 | B2 |
10285686 | Gammie et al. | May 2019 | B2 |
10376266 | Herman et al. | Aug 2019 | B2 |
10543090 | Griswold et al. | Jan 2020 | B2 |
10548733 | Purcell et al. | Feb 2020 | B2 |
10595994 | Christianson et al. | Mar 2020 | B1 |
10617523 | Purcell et al. | Apr 2020 | B2 |
10624743 | Keidar et al. | Apr 2020 | B2 |
10660753 | Pham et al. | May 2020 | B2 |
10667910 | Bishop et al. | Jun 2020 | B2 |
10675150 | Bishop et al. | Jun 2020 | B2 |
10682230 | Bishop et al. | Jun 2020 | B2 |
10925731 | Bishop et al. | Feb 2021 | B2 |
11083580 | Purcell et al. | Aug 2021 | B2 |
20030083674 | Gibbens | May 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030120341 | Shennib et al. | Jun 2003 | A1 |
20030130598 | Manning et al. | Jul 2003 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040044365 | Bachman | Mar 2004 | A1 |
20040049207 | Goldfarb et al. | Mar 2004 | A1 |
20040073216 | Lieberman | Apr 2004 | A1 |
20040091600 | Salome et al. | May 2004 | A1 |
20040097979 | Svanidze et al. | May 2004 | A1 |
20040162568 | Saadat et al. | Aug 2004 | A1 |
20040172046 | Hlavka et al. | Sep 2004 | A1 |
20050096694 | Lee | May 2005 | A1 |
20050119735 | Spence et al. | Jun 2005 | A1 |
20050177132 | Lentz et al. | Aug 2005 | A1 |
20050177180 | Kaganov et al. | Aug 2005 | A1 |
20050251210 | Westra et al. | Nov 2005 | A1 |
20070010857 | Sugimoto et al. | Jan 2007 | A1 |
20070038230 | Stone et al. | Feb 2007 | A1 |
20070038293 | St. Goar et al. | Feb 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070123979 | Perier et al. | May 2007 | A1 |
20070219565 | Saadat | Sep 2007 | A1 |
20080177281 | Weitzner et al. | Jul 2008 | A1 |
20080177304 | Westra et al. | Jul 2008 | A1 |
20080195126 | Solem | Aug 2008 | A1 |
20080226810 | Passe et al. | Sep 2008 | A1 |
20080228165 | Spence et al. | Sep 2008 | A1 |
20080228223 | Alkhatib | Sep 2008 | A1 |
20080288061 | Maurer et al. | Nov 2008 | A1 |
20080294188 | Appling et al. | Nov 2008 | A1 |
20090043153 | Zollinger et al. | Feb 2009 | A1 |
20090069847 | Hashiba et al. | Mar 2009 | A1 |
20090082828 | Ostroff | Mar 2009 | A1 |
20090088837 | Gillinov et al. | Apr 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20090312773 | Cabrera | Dec 2009 | A1 |
20090312790 | Forsberg et al. | Dec 2009 | A1 |
20100023118 | Medlock et al. | Jan 2010 | A1 |
20100042147 | Janovsky | Feb 2010 | A1 |
20100161041 | Maisano | Jun 2010 | A1 |
20100161042 | Maisano et al. | Jun 2010 | A1 |
20100161043 | Maisano et al. | Jun 2010 | A1 |
20100249919 | Gillinov et al. | Sep 2010 | A1 |
20100280604 | Zipory et al. | Nov 2010 | A1 |
20110011917 | Loulmet | Jan 2011 | A1 |
20110022083 | DiMatteo et al. | Jan 2011 | A1 |
20110040326 | Wei | Feb 2011 | A1 |
20110060407 | Ketai et al. | Mar 2011 | A1 |
20110106245 | Miller et al. | May 2011 | A1 |
20110257581 | Koziczynski et al. | Oct 2011 | A1 |
20110301698 | Miller et al. | Dec 2011 | A1 |
20120065464 | Ellis et al. | Mar 2012 | A1 |
20120095505 | Shluzas | Apr 2012 | A1 |
20120116418 | Belson et al. | May 2012 | A1 |
20120116489 | Khairkhahan et al. | May 2012 | A1 |
20120158021 | Morrill | Jun 2012 | A1 |
20120172915 | Fifer et al. | Jul 2012 | A1 |
20130035757 | Zentgraf et al. | Feb 2013 | A1 |
20130046380 | Maisano et al. | Feb 2013 | A1 |
20130096672 | Reich et al. | Apr 2013 | A1 |
20130158567 | Levin et al. | Jun 2013 | A1 |
20130190741 | Moll et al. | Jul 2013 | A1 |
20130197575 | Karapetian et al. | Aug 2013 | A1 |
20130197577 | Wolf et al. | Aug 2013 | A1 |
20130197578 | Gregoire et al. | Aug 2013 | A1 |
20130253639 | Alkhatib | Sep 2013 | A1 |
20140031926 | Kudlik et al. | Jan 2014 | A1 |
20140142687 | De Canniere et al. | May 2014 | A1 |
20140142689 | De Canniere et al. | May 2014 | A1 |
20140243877 | Lee et al. | Aug 2014 | A9 |
20140243963 | Sheps et al. | Aug 2014 | A1 |
20140350417 | Van Bladel et al. | Nov 2014 | A1 |
20150032127 | Gammie et al. | Jan 2015 | A1 |
20150119979 | Maisano et al. | Apr 2015 | A1 |
20150182255 | Shivkumar | Jul 2015 | A1 |
20150230919 | Chau et al. | Aug 2015 | A1 |
20150250590 | Gries et al. | Sep 2015 | A1 |
20150272586 | Herman et al. | Oct 2015 | A1 |
20150313620 | Suri | Nov 2015 | A1 |
20150342737 | Biancucci et al. | Dec 2015 | A1 |
20150359632 | Navia et al. | Dec 2015 | A1 |
20160058557 | Reich et al. | Mar 2016 | A1 |
20160143737 | Zentgraf et al. | May 2016 | A1 |
20160174964 | Tobis | Jun 2016 | A1 |
20160192925 | Bachman | Jul 2016 | A1 |
20160228117 | Borden | Aug 2016 | A1 |
20160240941 | Stavrianoudakis | Aug 2016 | A1 |
20160256269 | Cahalane et al. | Sep 2016 | A1 |
20160262741 | Gilmore et al. | Sep 2016 | A1 |
20160310701 | Pai | Oct 2016 | A1 |
20160354082 | Oz et al. | Dec 2016 | A1 |
20160367367 | Maisano et al. | Dec 2016 | A1 |
20170042658 | Lee et al. | Feb 2017 | A1 |
20170043120 | Heideman et al. | Feb 2017 | A1 |
20170079797 | Maisano et al. | Mar 2017 | A1 |
20170086975 | Gilmore et al. | Mar 2017 | A1 |
20170119368 | Solem | May 2017 | A1 |
20170135817 | Tylis et al. | May 2017 | A1 |
20170156719 | Tobis | Jun 2017 | A1 |
20170156861 | Longoria et al. | Jun 2017 | A1 |
20170202657 | Lee et al. | Jul 2017 | A1 |
20170202669 | Schaffner et al. | Jul 2017 | A1 |
20170252032 | Hiorth et al. | Sep 2017 | A1 |
20170258464 | Gammie et al. | Sep 2017 | A1 |
20170258588 | Zipory et al. | Sep 2017 | A1 |
20170258594 | Gilmore et al. | Sep 2017 | A1 |
20170273681 | Gilmore et al. | Sep 2017 | A1 |
20170304051 | Tobis et al. | Oct 2017 | A1 |
20170340433 | Berra et al. | Nov 2017 | A1 |
20170340443 | Stearns et al. | Nov 2017 | A1 |
20180064535 | Gilmore et al. | Mar 2018 | A1 |
20180185153 | Bishop et al. | Jul 2018 | A1 |
20180185179 | Murphy et al. | Jul 2018 | A1 |
20180206992 | Brown | Jul 2018 | A1 |
20180221148 | Guidotti et al. | Aug 2018 | A1 |
20180249993 | Denti et al. | Sep 2018 | A1 |
20180289480 | D'ambra et al. | Oct 2018 | A1 |
20180303614 | Schaffner et al. | Oct 2018 | A1 |
20180311007 | Tyler, II et al. | Nov 2018 | A1 |
20180318079 | Patel et al. | Nov 2018 | A1 |
20180318083 | Bolling et al. | Nov 2018 | A1 |
20180344311 | Gilmore et al. | Dec 2018 | A1 |
20180353297 | Griffin | Dec 2018 | A1 |
20180360439 | Niland et al. | Dec 2018 | A1 |
20190000624 | Wilson et al. | Jan 2019 | A1 |
20190015205 | Rajagopal et al. | Jan 2019 | A1 |
20190069891 | Gilmore et al. | Mar 2019 | A1 |
20190083085 | Gilmore et al. | Mar 2019 | A1 |
20190105027 | Gilmore et al. | Apr 2019 | A1 |
20190117401 | Cortez, Jr. et al. | Apr 2019 | A1 |
20190151090 | Gross et al. | May 2019 | A1 |
20190175345 | Schaffner et al. | Jun 2019 | A1 |
20190175346 | Schaffner et al. | Jun 2019 | A1 |
20190183480 | Hiorth et al. | Jun 2019 | A1 |
20190183648 | Trapp et al. | Jun 2019 | A1 |
20190216599 | Alkhatib | Jul 2019 | A1 |
20190216601 | Purcell et al. | Jul 2019 | A1 |
20190240023 | Spence et al. | Aug 2019 | A1 |
20190314155 | Franklin et al. | Oct 2019 | A1 |
20190328530 | McDaniel et al. | Oct 2019 | A1 |
20190365539 | Rabito et al. | Dec 2019 | A1 |
20190380699 | Bak-Boychuk et al. | Dec 2019 | A1 |
20200155798 | Yang et al. | May 2020 | A1 |
20200297489 | Bishop et al. | Sep 2020 | A1 |
20200330228 | Anderson et al. | Oct 2020 | A1 |
20200345496 | Bishop et al. | Nov 2020 | A1 |
20200390554 | Pham et al. | Dec 2020 | A1 |
20210186699 | Bishop et al. | Jun 2021 | A1 |
20210213259 | Giasolli et al. | Jul 2021 | A1 |
20220338990 | Hammill et al. | Oct 2022 | A1 |
20220339437 | Sorajja | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
101495049 | Jul 2009 | CN |
101553190 | Oct 2009 | CN |
101184454 | Oct 2010 | CN |
101902975 | Dec 2010 | CN |
103491901 | Jan 2014 | CN |
103635160 | Mar 2014 | CN |
103813757 | May 2014 | CN |
103889345 | Jun 2014 | CN |
104000625 | Aug 2014 | CN |
104582637 | Apr 2015 | CN |
105555229 | May 2016 | CN |
107569301 | Jan 2018 | CN |
0476047 | Mar 1992 | EP |
1400537 | Mar 2004 | EP |
1 898 802 | Sep 2015 | EP |
2 979 647 | Feb 2016 | EP |
3562410 | Nov 2019 | EP |
2889416 | Feb 2007 | FR |
2009-500105 | Jan 2009 | JP |
2014-523282 | Sep 2014 | JP |
2019-500998 | Jan 2019 | JP |
2219853 | Dec 2003 | RU |
WO 2007061834 | May 2007 | WO |
WO 2007100268 | Sep 2007 | WO |
WO 2008005747 | Jan 2008 | WO |
WO 2010128502 | Nov 2010 | WO |
WO 2012040865 | Apr 2012 | WO |
2012167120 | Dec 2012 | WO |
WO 2013179295 | Dec 2013 | WO |
WO 2014134185 | Sep 2014 | WO |
WO 2017066888 | Apr 2017 | WO |
WO 2017066889 | Apr 2017 | WO |
WO 2017066890 | Apr 2017 | WO |
WO 2017117560 | Jul 2017 | WO |
WO 2018035378 | Feb 2018 | WO |
WO 2018126188 | Jul 2018 | WO |
WO 2018148324 | Aug 2018 | WO |
WO 2018148364 | Aug 2018 | WO |
WO 2018160456 | Sep 2018 | WO |
WO 2018227048 | Dec 2018 | WO |
WO 2019013994 | Jan 2019 | WO |
WO 2019074815 | Apr 2019 | WO |
WO 2019177909 | Sep 2019 | WO |
WO 2019195860 | Oct 2019 | WO |
WO 2019231744 | Dec 2019 | WO |
WO 2019236654 | Dec 2019 | WO |
WO 2020106705 | May 2020 | WO |
WO 2020109594 | Jun 2020 | WO |
WO 2020109596 | Jun 2020 | WO |
WO 2020109599 | Jun 2020 | WO |
WO 2020123719 | Jun 2020 | WO |
WO 2020219281 | Oct 2020 | WO |
WO 2020256853 | Dec 2020 | WO |
WO 2021257278 | Dec 2021 | WO |
WO 2022232070 | Nov 2022 | WO |
Entry |
---|
Carpentier, M.D., Alain, “Cardiac Valve Surgery—the ‘French Correction’”, The Journal of Thoracic and Cardiovascular Surgery, Sep. 1983, vol. 86, No. 3, pp. 323-337. |
Júnior, Francisco Gregori et al., “Surgical Repair of Chordae Tendineae Rupture After Degenerative Valvular Regurgitation Using Standardized Bovine Pericardium”, Revista Brasileira de Cirurgia Cardiovascular, Jan. 2013, vol. 28, No. 1, pp. 36-46. |
Kobayashi et al., “Ten Year Experience of Chordal Replacement with Expanded Polytetrafluoroethylene in Mitral Valve Repair”, Circulation, American Heart Association, Nov. 7, 2000, pp. III-30-34. |
Shikata et al., “Repair of Congenitally Absent Chordae in a Tricuspid Valve Leaflet with Hypoplastic Papillary Muscle Using Artificial Chordae”, J Card Surg, 25:737-739 (2010). |
International Search Report and Written Opinion received in PCT Application No. PCT/US2016/069567, dated Mar. 23, 2017 in 13 pages. |
International Preliminary Report on Patentability received in PCT Application No. PCT/US2016/069567, dated Jul. 12, 2018 in 6 pages. |
International Search Report and Written Opinion received in PCT Application No. PCT/US2017/069046, dated Jun. 14, 2018 in 10 pages. |
International Search Report and Written Opinion received in PCT Application No. PCT/US2019/021480, dated Jul. 15, 2019 in 12 pages. |
International Search Report and Written Opinion received in PCT Application No. PCT/US2019/065814, dated Apr. 1, 2020 in 14 pages. |
Number | Date | Country | |
---|---|---|---|
20230397992 A1 | Dec 2023 | US |
Number | Date | Country | |
---|---|---|---|
62383338 | Sep 2016 | US | |
62273300 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16024439 | Jun 2018 | US |
Child | 18335589 | US | |
Parent | PCT/US2016/069567 | Dec 2016 | WO |
Child | 16024439 | US |